Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UKs fastest growing listed companies.
The event on Wednesday 4 September 2019 in London will include:
An opportunity for you to talk directly with the directors and ask your questions about the companies core strengths and their short and long-term business strategy
Meet fellow investors and share your investing experience
Complimentary drinks and snacks
More about the companies presenting:
Allergy Therapeutics (AGY) is a pharmaceutical products company. It develops therapies for allergy based diseases, having its primary market in Germany.
Belvoir Lettings (BLV) is uniquely positioned within the property sector, benefiting from the agility of a franchise business model compared with the larger corporate players, whilst providing our networks with the Central Office systems and support, not available to the smaller independent agents.
CentralNic Group (CNIC) provides registry, registrar & enterprise services & strategic consultancy for new Top Level Domains (TLDs), Country Code TLDs (ccTLDs) & Second-Level Domains (SLDs) and it is the owner & registrant for a portfolio of domain names.
Open Orphan (ORPH) a European-focussed, rare and orphan drug consulting services platform. The Company will target the fragmented orphan drug services market in Europe
Who Should Attend
The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors.
Evening timings
18.00
Registration and coffee
18.30
Presentations
Nick Wykeman, CFO - Allergy Therapeutics (AGY)
Dorian Gonsalves, CEO - Belvoir Group (BLV)
Cathal Friel, Executive Chairman - Open Orphan (ORPH)
Ben Crawford, CEO - CentralNic Group (CNIC)
20.30
Drinks reception and canapés
21.30
Close
Venue
Sponsored by
Featured Companies
